Progesterone and estrogen receptor expression and activity in human non-small cell lung cancer

Steroids

Volumn 76, Issue 9, 2011, Pages 910-920

  Marquez Garban, Diana C ^a   Mah, Vei ^a   Alavi, Mohammad ^a   Maresh, Erin L ^a   Chen, Hsiao Wang ^a   Bagryanova, Lora ^a   Horvath, Steve ^a   Chia, David ^a   Garon, Edward ^a   Goodglick, Lee ^a   Pietras, Richard J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cancer stem cells; Estrogen; Lung cancer; Progesterone; Steroid hormone receptors; VEGF

Indexed keywords

ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; GESTAGEN; PROGESTERONE RECEPTOR; VASCULAR ENDOTHELIAL GROWTH INHIBITOR;

ANGIOGENESIS; ARTICLE; CANCER CELL; CANCER GROWTH; CANCER STEM CELL; CELL PROLIFERATION; ENDOTHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LUNG NON SMALL CELL CANCER; MALE; PROGNOSIS; PROTEIN EXPRESSION; STEM CELL;

ALDEHYDE DEHYDROGENASE; ANIMALS; ANTIGENS, CD; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; CELL NUCLEUS; CELL PROLIFERATION; CULTURE MEDIA, CONDITIONED; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; ESTRADIOL; ESTROGENS; FEMALE; GLYCOPROTEINS; HUMANS; LUNG NEOPLASMS; MALE; MICE; MICE, SCID; MIFEPRISTONE; NEOPLASM TRANSPLANTATION; NEOPLASTIC STEM CELLS; PEPTIDES; PROGESTINS; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; TRANSCRIPTION, GENETIC; UMBILICAL CORD; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

NICOTIANA TABACUM;

EID: 79959907536     PISSN: 0039128X     EISSN: 18785867     Source Type: Journal    
DOI: 10.1016/j.steroids.2011.04.015     Document Type: Article

References (77)

1. Patel JD, Bach PB, Kris MG. Lung cancer in US women: a contemporary epidemic. JAMA 2004;291:1763-8. (Pubitemid 38489898)
2. Jemal A, Ward E, Thun M. Declining death rates reflect progress against cancer. PLoS One 2010;5:e9584, doi:10.1371/journal.pone.0009584.
3. Subramanian J, Govindan R. Lung cancer in never smokers: a review. J Clin Oncol 2007;25:561-70. (Pubitemid 350002964)
4. Stabile LP, Davis AL, Gubish CT, Hopkins TM, Luketich JD, Christie N, et al. Human non-small cell lung tumors and cells derived from normal lung express both estrogen receptor alpha and beta and show biological responses to estrogen. Cancer Res 2002;62:2141-50. (Pubitemid 34408463)
5. Mah V, Seligson D, Li A, Marquez DIW, Elshimali Y, Fishbein MC, et al. Aromatase expression predicts survival in women with early stage non-small cell lung cancer. Cancer Res 2007;67:10484-90. (Pubitemid 350070824)
6. Weinberg OK, Marquez-Garban DC, Fishbein MC, Goodglick L, Garban HJ, Dubinett SM, et al. Aromatase inhibitors in human lung cancer therapy. Cancer Res 2005;65:11287-91. (Pubitemid 41821684)
7. Pietras RJ, Marquez D, Chen H, Tsai E, Weinberg O, Fishbein M. Estrogen and growth factor receptor interactions in human breast and non-small cell lung cancer cells. Steroids 2005;70:372-81. (Pubitemid 40616035)
8. Niikawa H, Suzuki T, Miki Y, Suzuki S, Nagasaki S, Akahira J, et al. Intratumoral estrogens and estrogen receptors in human non-small cell lung carcinoma. Clin Cancer Res 2008;14:4417-26.
9. Mollerup S, Jorgensen K, Berge G, Haugen A. Expression of estrogen receptors alpha and beta in human lung tissue and cell lines. Lung Cancer 2002;37:153-9. (Pubitemid 34831807)
10. Taioli E, Wynder EL. Endocrine factors and adenocarcinoma of the lung in women. J Natl Cancer Inst 1994;86:869-70.
11. Beattie CW, Hansen NW, Thomas PA. Steroid receptors in human lung cancer. Cancer Res 1985;45:4206-14. (Pubitemid 16224875)
12. Ganti AK, Sahmoun AE, Panwalkar AW, Tendulkar KK, Potti A. Hormone replacement therapy is associated with decreased survival in women with lung cancer. J Clin Oncol 2006;24:59-63. (Pubitemid 46630494)
13. Hershberger PA, Vasquez AC, Kanterewicz B, Land S, Siegfried JM, Nichols M. Regulation of endogenous gene expression in human non-small cell lung cancer cells by estrogen receptor ligands. Cancer Res 2005;65:1598-605. (Pubitemid 40270190)
14. Kerr 2nd A, Eliason JF, Wittliff JL. Steroid receptor and growth factor receptor expression in human nonsmall cell lung cancers using cells procured by lasercapture microdissection. Adv Exp Med Biol 2008;617:377-84.
15. Pietras RJ, Marquez-Garban DC. Membrane-associated estrogen receptor signaling pathways in human cancers. Clin Cancer Res 2007;13:4672-6. (Pubitemid 47294772)
16. Norfleet AM, Clarke CH, Gametchu B, Watson CS. Antibodies to the estrogen receptor-alpha modulate rapid prolactin release from rat pituitary tumor cells through plasma membrane estrogen receptors. FASEB J 2000;14:157-65. (Pubitemid 30051533)
17. Razandi M, Pedram A, Greene GL, Levin ER. Cell membrane and nuclear estrogen receptors (ERs) originate from a single transcript: studies of ERalpha and ERbeta expressed in Chinese hamster ovary cells. Mol Endocrinol 1999;13:307-19. (Pubitemid 29068005)
18. Gruber CJ, Tschugguel W, Schneeberger C, Huber JC. Production and actions of estrogens. N Engl J Med 2002;346:340-52.
19. Massaro D, Clerch LB, Massaro GD. Estrogen receptor-alpha regulates pulmonary alveolar loss and regeneration in female mice: morphometric and gene expression studies. Am J Physiol Lung Cell Mol Physiol 2007;293:L222-8.
20. Morani A, Warner M, Gustafsson J-A. Biological functions and clinical implications of oestrogen receptors alpha and beta in epithelial tissues. J Intern Med 2008;264:128-42. (Pubitemid 351962577)
21. Chotirmall SH, Greene CM, Oglesby IK, Thomas W, O'Neill SJ, Harvey BJ, et al. 17beta-estradiol inhibits IL-8 in cystic fibrosis by up-regulating secretory leucoprotease inhibitor. Am J Respir Crit Care Med 2010;182(1):62-72.
22. Fasco MJ, Hurteau GJ, Spivack SD. Gender-dependent expression of alpha and beta estrogen receptors in human nontumor and tumor lung tissue. Mol Cell Endocrinol 2002;188:125-40. (Pubitemid 34242672)
23. Stabile LP, Lyker JS, Gubish CT, Zhang W, Grandis JR, Siegfried JM. Combined targeting of the estrogen receptor and the epidermal growth factor receptor in non-small cell lung cancer shows enhanced antiproliferative effects. Cancer Res 2005;65:1459-70. (Pubitemid 40270175)
24. Kawai H, Ishii A, Washiya K, Konno T, Kon H, Yamaya C, et al. Combined overexpression of EGFR and estrogen receptor alpha correlates with a poor outcome in lung cancer. Anticancer Res 2005;25:4693-8. (Pubitemid 41729532)
25. Raso M, Behrens C, Herynk M, Liu S, Prudkin L, Ozburn N, et al. Immunohistochemical expression of estrogen and progesterone receptors identifies a subset of NSCLCs and correlates with EGFR mutation. Clin Cancer Res 2009;15:5359-68.
26. Hershberger P, Stabile L, Kanterewicz B, Rothstein M, Gubish C, Land S, et al. Estrogen receptor beta subtype-specific ligands increase transcription, p44/p42 mitogen activated protein kinase (MAPK) activation and growth in human non-small cell lung cancer cells. J Steroid Biochem Mol Biol 2009;116:102-9.
27. Márquez-Garbán D, Chen HW, Fishbein M, Goodglick L, Pietras RJ. Estrogen receptor signaling pathways in human non-small cell lung cancer. Steroids 2007;72:135-43. (Pubitemid 46273500)
28. The Coronary Drug Project Research Group. The Coronary Drug Project: findings leading to discontinuation of the 2.5 mg/day estrogen group. JAMA 1973;226:652-7.
29. Chlebowski RT, Schwartz A, Wakelee H, Anderson G, Stefanick M, Manson J, et al. Oestrogen plus progestin and lung cancer in postmenopausal women (Women's Health Initiative trial): a post-hoc analysis of a randomised controlled trial. Lancet 2009;374:1243-51.
30. Slatore C, Chien J, Au D, Satia J, White E. Lung cancer and hormone replacement therapy: association in the vitamins and lifestyle study. J Clin Oncol 2010;28:1540-6.
31. Schabath M, Wu X, Vassilopoulou-Sellin R, Vaporciyan A, Spitz M. Hormone replacement therapy and lung cancer risk: a case-control analysis. Clin Cancer Res 2004;10:113-23. (Pubitemid 38114169)
32. Chlebowski RT, Anderson GL, Manson JE, Schwartz AG, Wakelee H, Gass M, et al. Lung cancer among postmenopausal women treated with estrogen alone in the women's health initiative randomized trial. J Natl Cancer Inst 2010;102:1413-21.
33. Ishibashi H, Suzuki T, Suzuki S, Niikawa H, Lu L, Miki Y, et al. Progesterone receptor in non-small cell lung cancer - a potent prognostic factor and possible target for endocrine therapy. Cancer Res 2005;65:6450-8. (Pubitemid 40994434)
34. Su JM, Hsu HK, Chang H, Lin S, Chang H, Huang M, et al. Expression of estrogen and progesterone receptors in non-small cell lung cancer: immunohistochemical study. Anticancer Res 1996;16:3803-6. (Pubitemid 27085052)
35. Stabile LP, Dacic S, Land SR, Lenzner D, Dhir R, Aquafondata M, et al. Combined analysis of estrogen receptor beta-1 and progesterone receptor expression identifies lung cancer patients with poor outcome. Clin Cancer Res 2011;17(1):154-64.
36. Skov BG, Fischer BM, Pappot H. Oestrogen receptor beta over expression in males with non-small cell lung cancer is associated with better survival. Lung Cancer 2008;59:88-94.
37. Di Nunno L, Larsson LG, Rinehart JJ, Beissner RS. Estrogen and progesterone receptors in non-small cell lung cancer in 248 consecutive patients who underwent surgical resection. Arch Pathol Lab Med 2000;124:1467-70.
38. Abe K, Miki Y, Ono K, Mori M, Kakinuma H, Kou Y, et al. Highly concordant coexpression of aromatase and estrogen receptor beta in non-small cell lung cancer. Hum Pathol 2010;41:190-8.
39. Check JH, Sansoucie L, Chern J, Dix E. Mifepristone treatment improves length and quality of survival of mice with spontaneous lung cancer. Anticancer Res 2010;30(1):119-22.
40. Trotter A, Kipp M, Schrader RM, Beyer C. Combined application of 17β-estradiol and progesterone enhance vascular endothelial growth factor and surfactant protein expression in cultured embryonic lung cells of mice. Int J Pediatr 2009:1-8.
41. Joshi P, Jackson HW, Beristain AG, Di Grappa MA, Mote PA, Clarke CL, et al. Progesterone induces adult mammary stem cell expansion. Nature 2010;465:803-7.
42. Asselin-Labat M-L, Vaillant F, Sheridan JM, Pal B, Wu D, Simpson ER, et al. Control of mammary stem cell function by steroid hormone signaling. Nature 2010;465:798-802.
43. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1995;1:27-31.
44. Ferrara N. Role of vascular endothelial growth factor in physiologic and pathologic angiogenesis: therapeutic implications. Semin Oncol 2002;29:10-4.
45. Zhan P, Wang J, Lv X, Wnag Q, Qui L, Lin X, et al. Prognostic value of vascular endothelial growth factor expression in patients with lung cancer: a systematic review with meta-analysis. J Thorac Oncol 2009;4:1094-103.
46. Reck M, Crino L. Advances in anti-VEGF and anti-EGFR therapy for advanced non-small cell lung cancer. Lung Cancer 2009;63:1-9.
47. Farha S, Asosingh K, Laskowski D, Licina L, Sekiguchi H, Losordo D, et al. Pulmonary gas transfer related to markers of angiogenesis during the menstrual cycle. J Appl Physiol 2007;103:1789-95. (Pubitemid 350033867)
48. Marquez DC, Chen HW, Curran EM, Welshons WV, Pietras RJ. Estrogen receptors in membrane lipid rafts and signal transduction in breast cancer. Mol Cell Endocrinol 2006;246:91-100. (Pubitemid 43238401)
49. Song RX, Barnes CJ, Zhang Z, Bao Y, Kumar R, Santen RJ. The role of Shc and insulin-like growth factor 1 receptor in mediating the translocation of estrogen receptor alpha to the plasma membrane. Proc Natl Acad Sci USA 2004;101:2076-81. (Pubitemid 38229017)
50. Li D, Williams JI, Pietras RJ. Squalamine and cisplatin block angiogenesis and growth of human ovarian cancer cells with or without HER-2 gene overexpression. Oncogene 2002;21:2805-14. (Pubitemid 34499377)
51. Petit A, Rak J, Hung M, Rockwell P, Goldstein N, Fendly B, et al. Neutralizing antibodies against epidermal growth factor and ErbB-2/neu receptor tyrosine kinases down-regulate vascular endothelial growth factor production by tumor cells in vitro and in vivo: angiogenic implications for signal transduction therapy of solid tumors. Am J Pathol 1997;151:1523-30. (Pubitemid 27527914)
52. Pietras RJ. Interactions between estrogen and growth factor receptors in human breast cancers and the tumor-associated vasculature. Breast J 2003;9:361-73. (Pubitemid 37158909)
53. Liang Y, Hyder SM. Proliferation of endothelial and tumor epithelial cells by progestin-induced vascular endothelial growth factor from human breast cancer cells: paracrine and autocrine effects. Endocrinology 2005;146:3632-41. (Pubitemid 41058135)
54. Ginestier C, Hur M, Charafe-Jauffret E, Monville F, Dutcher J, Brown M, et al. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell 2007;1:555-67. (Pubitemid 350056407)
55. Korkaya H, Paulson A, Iovino F, Wicha M. HER2 regulates the mammary stem/progenitor cell population driving tumorigenesis and invasion. Oncogene 2008;27:6120-30.
56. Stuelten CH, Mertins SD, Busch J, Gowens M, Scudiero D, Burkett M, et al. Complex display of putative tumor stem cell markers in the NCI60 tumor cell line panel. Stem Cells 2010;28:649-60.
57. Dontu G, Abdallah W, Foley J, Jackson K, Clarke M, Kawamura M, et al. In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. Genes Dev 2003;17:1253-70.
58. Levina V, Marrangoni AM, DeMarco R, Gorelik E, Lokshin AE. Drug-selected human lung cancer stem cells: cytokine network, tumorigenic and metastatic properties. PLoS One 2008;3(8):e3077, doi:10.1371/journal.pone.0003077.
59. Mumenthaler S, Yoon N, Li A, Mah V, Chang G, Nooraie F, et al. Tissue microarrays: construction and utilization for biomarker studies. In: Hayat MA, editor. Methods of cancer diagnosis, therapy, and prognosis. Netherlands: Springer; 2008. p. 217-34.
60. Ooi AT, Mah V, Nickerson DW, Gilbert JL, Ha VL, Hegab AE, et al. Presence of a putative tumor-initiating progenitor cell population predicts poor prognosis in smokers with non-small cell lung cancer. Cancer Res 2010;70:6639-48.
61. Yanagawa J, Walser TC, Zhu LX, Hong L, Fishbein MC, Mah V, et al. Snail promotes CXCR2 ligand-dependent tumor progression in non-small cell lung carcinoma. Clin Cancer Res 2009;15:6820-9.
62. Takeuchi T, Tomida S, Yatabe Y, Kosaka T, Osada H, Yanagisawa K, et al. Expression profile-defined classification of lung adenocarcinoma shows close relationship with underlying major genetic changes and clinicopathologic behaviors. J Clin Oncol 2006;24:1679-88. (Pubitemid 46622139)
63. Yoon NK, Maresh EL, Elshimali Y, Li A, Horvath S, Seligson DB, et al. Elevated MED28 expression predicts poor outcome in women with breast cancer. BMC Cancer 2010;10:335.
64. Nishizawa Y, Yamasaki M, Katayama H, Amakata Y, Fushiki S, Nishizawa Y. Establishment of a progesterone-sensitive cell line from human lung cancer. Oncol Rep 2007;18(3):685-90.
65. Tirino V, Camerlingo R, Franco R, Malanga D, La Rocca A, Viglietto G, et al. The role of CD133 in the identification and characterisation of tumourinitiating cells in non-small-cell lung cancer. Europ J Cardiothoracic Surg 2009;36:446-53.
66. Chen Y, Hsu H, Chen Y, Tsai T, How C, Wang C, et al. Oct-4 expression maintained cancer stem-like properties in lung cancer-derived CD133-positive cells. PLoS One 2008;3(7):e2637, doi:10.1371/journal.pone.0002637.
67. Jiang F, Qiu Q, Khanna A, Todd NW, Deepak J, Xing L, et al. Aldehyde dehydrogenase 1 is a tumor stem cell-associated marker in lung cancer. Mol Cancer Res 2009;7(3):330-8.
68. Keck C, Herchenbach D, Pfisterer J, Breckwoldt M. Effects of 17beta-estradiol and progesterone on interleukin-6 production and proliferation of human umbilical vein endothelial cells. Exp Clin Endocrinol Diabetes 1998;106(4):334-9. (Pubitemid 28457015)
69. Lange CA, Shen T, Horwitz KB. Phosphorylation of human progesterone receptors at serine-294 by mitogen-activated protein kinase signals their degradation by the 26S proteosome. Proc Natl Acad Sci USA 2000;97:1032-7. (Pubitemid 30080807)
70. Boonyaratanakornkit V, Bi Y, Rudd M, Edwards DP. The role and mechanism of progesterone receptor activation of extranuclear signaling pathways in regulating gene transcription and cell cycle progression. Steroids 2008;73:922-8.
71. Krishnamurthy S, Dong Z, Vodopyanov D, Imai A, Helman JI, Prince ME, et al. Endothelial cell-initiated signaling promotes the survival and self-renewal of cancer stem cells. Cancer Res 2010;70(23):9969-78.
72. Groshong S, Owen G, Grimison B, Schauer I, Todd M, Langan T, et al. Biphasic regulation of breast cancer cell growth by progesterone: Role of the cyclin-dependent kinase inhibitors, p21 and p27Kip1. Mol Endocrinol 1997;11:1593-607. (Pubitemid 27435408)
73. Leslie K, Stein M-P, Kumar NS, Dai D, Stephens J, Wandinger-Ness A, et al. Progesterone receptor isoform identification and subcellular localization in endometrial cancer. Gynecol Oncol 2005;96:32-41. (Pubitemid 39612414)
74. Zhang G, Liu X, Farkas AM, Parwani AV, Lathrop KL, Lenzner D, et al. Estrogen receptor beta functions through nongenomic mechanisms in lung cancer cells. Mol Endocrinol 2009;23(2):146-56.
75. Hammond MEH, Hayes DF, Dowsett M, Allred DC, Hagerty KL, Badve S, et al. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. J Clin Oncol 2010;28(16):2784-95.
76. Allred DC, Carlson RW, Berry DA, Burstein H, Edge S, Goldstein L, et al. NCCN Task Force Report: estrogen receptor and progesterone receptor testing in breast cancer by immunohistochemistry. J Natl Compr Cancer Network 2009;7 (Suppl. 6):s1-22.
77. Filardo EJ, Quinn JA, Sabo E. Association of the membrane estrogen receptor, GPR30, with breast tumor metastasis and transactivation of the epidermal growth factor receptor. Steroids 2008;73(9-10):870-3.